Cardiosense, Inc.

Cardiosense, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on May 22, 2026 and the most recent on May 22, 2026 (PCWP Analysis Software). Its most common review panel is Cardiovascular (1 device).